Lipitor may be a novel therapeutic option in patients with ulcerative colitis, according to study results published in Journal of the American Medical Informatics Association.

“Long-term atorvastatin (Lipitor) use is associated with reduced rate of colectomy in patients with UC,” Purvesh Khatri, PhD, from the Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University in California, told Healio Gastroenterology. “Our results also suggest that it may also be associated with lower rates of hospitalization and new steroid prescriptions.”

Full Article: